BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 22067384)

  • 1. Activity of alemtuzumab monotherapy in treatment-naive, relapsed, and refractory severe acquired aplastic anemia.
    Scheinberg P; Nunez O; Weinstein B; Scheinberg P; Wu CO; Young NS
    Blood; 2012 Jan; 119(2):345-54. PubMed ID: 22067384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Horse versus rabbit antithymocyte globulin in acquired aplastic anemia.
    Scheinberg P; Nunez O; Weinstein B; Scheinberg P; Biancotto A; Wu CO; Young NS
    N Engl J Med; 2011 Aug; 365(5):430-8. PubMed ID: 21812672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of rabbit antithymocyte globulin with cyclosporine in comparison to horse antithymocyte globulin as a first-line treatment in adult patients with severe aplastic anemia: a single-center retrospective study.
    Shin SH; Yoon JH; Yahng SA; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Kim HJ; Cho SG; Kim DW; Min WS; Park CW; Lee JW
    Ann Hematol; 2013 Jun; 92(6):817-24. PubMed ID: 23318980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of early mortality after rabbit antithymocyte globulin as first-line treatment in severe aplastic anemia.
    Atta EH; Lima CBL; Dias DSP; Clé DV; Bonduel MM; Sciuccati GB; Medeiros LA; Oliveira MM; Salvino MA; Garanito MP; Blum Fonseca PB; Saad STO; Calado RT; Scheinberg P
    Ann Hematol; 2017 Nov; 96(11):1907-1914. PubMed ID: 28815305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct EBV and CMV reactivation patterns following antibody-based immunosuppressive regimens in patients with severe aplastic anemia.
    Scheinberg P; Fischer SH; Li L; Nunez O; Wu CO; Sloand EM; Cohen JI; Young NS; John Barrett A
    Blood; 2007 Apr; 109(8):3219-24. PubMed ID: 17148582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alemtuzumab in relapsed immune severe aplastic anemia: Long-term results of a phase II study.
    Aggarwal N; Manley AL; Shalhoub R; Durrani J; Rios O; Lotter J; Patel BA; Wu CO; Young NS; Groarke EM
    Am J Hematol; 2023 Jun; 98(6):932-939. PubMed ID: 37021397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rabbit antithymocyte globulin dose does not affect response or survival as first-line therapy for acquired aplastic anemia: a multicenter retrospective study.
    Clé DV; Atta EH; Dias DSP; Lima CBL; Bonduel M; Sciuccati G; Medeiros LA; de Oliveira MM; Blum Fonseca PB; Saad STO; Hamerschlak N; Salvino MA; Garanito MP; Pazin-Filho A; Scheinberg P; Calado RT
    Ann Hematol; 2018 Nov; 97(11):2039-2046. PubMed ID: 29978284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up study of porcine anti-human thymocyte immunoglobulin therapy combined with cyclosporine for severe aplastic anemia.
    Chen M; Liu C; Zhuang J; Zou N; Xu Y; Zhang W; Li J; Duan M; Zhu T; Cai H; Cao X; Wang S; Zhou D; Han B
    Eur J Haematol; 2016 Mar; 96(3):291-6. PubMed ID: 25996247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modified immunosuppressive therapy with porcine antilymphocyte globulin plus delayed cyclosporine A in children with severe aplastic anemia.
    Cui Q; Sha P; Chen H; Shen H; Qin L; Li Z; Wu T; Wang Z
    Int J Hematol; 2018 Jan; 107(1):64-68. PubMed ID: 28900860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Horse antithymocyte globulin as salvage therapy after rabbit antithymocyte globulin for severe aplastic anemia.
    Scheinberg P; Townsley D; Dumitriu B; Scheinberg P; Weinstein B; Rios O; Wu CO; Young NS
    Am J Hematol; 2014 May; 89(5):467-9. PubMed ID: 24415649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies in the treatment of aplastic anemia.
    Gómez-Almaguer D; Jaime-Pérez JC; Ruiz-Arguelles GJ
    Arch Immunol Ther Exp (Warsz); 2012 Apr; 60(2):99-106. PubMed ID: 22307362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of severe aplastic anemia with a combination of horse antithymocyte globulin and cyclosporine, with or without sirolimus: a prospective randomized study.
    Scheinberg P; Wu CO; Nunez O; Scheinberg P; Boss C; Sloand EM; Young NS
    Haematologica; 2009 Mar; 94(3):348-54. PubMed ID: 19181786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent developments in drug therapy for aplastic anemia.
    Willis L; Rexwinkle A; Bryan J; Kadia TM
    Ann Pharmacother; 2014 Nov; 48(11):1469-78. PubMed ID: 25184310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rabbit antithymocyte globulin and cyclosporine as first-line therapy for children with acquired aplastic anemia.
    Takahashi Y; Muramatsu H; Sakata N; Hyakuna N; Hamamoto K; Kobayashi R; Ito E; Yagasaki H; Ohara A; Kikuchi A; Morimoto A; Yabe H; Kudo K; Watanabe K; Ohga S; Kojima S;
    Blood; 2013 Jan; 121(5):862-3. PubMed ID: 23372154
    [No Abstract]   [Full Text] [Related]  

  • 15. Rabbit antithymocyte globulin treatment in childhood acquired severe aplastic anemia.
    Karapinar DY; Karadaş N; Ay Y; Akin M; Balkan C; Aydinok Y; Kavakli K
    Pediatr Hematol Oncol; 2014 Feb; 31(1):20-8. PubMed ID: 23627541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcome after immunosuppressive therapy with horse or rabbit antithymocyte globulin and cyclosporine for severe aplastic anemia in children.
    Jeong DC; Chung NG; Cho B; Zou Y; Ruan M; Takahashi Y; Muramatsu H; Ohara A; Kosaka Y; Yang W; Kim HK; Zhu X; Kojima S
    Haematologica; 2014 Apr; 99(4):664-71. PubMed ID: 24213150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective study of rabbit antithymocyte globulin and cyclosporine for aplastic anemia from the EBMT Severe Aplastic Anaemia Working Party.
    Marsh JC; Bacigalupo A; Schrezenmeier H; Tichelli A; Risitano AM; Passweg JR; Killick SB; Warren AJ; Foukaneli T; Aljurf M; Al-Zahrani HA; Höchsmann B; Schafhausen P; Roth A; Franzke A; Brummendorf TH; Dufour C; Oneto R; Sedgwick P; Barrois A; Kordasti S; Elebute MO; Mufti GJ; Socie G;
    Blood; 2012 Jun; 119(23):5391-6. PubMed ID: 22544699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppressive therapy (IST) in adult patients with acquired aplastic anemia (AA): A single-center experience over the past 15 years.
    Alashkar F; Oelmüller M; Herich-Terhürne D; Turki AT; Schmitz C; Vance C; Dührsen U; Röth A
    Eur J Haematol; 2019 Jul; 103(1):18-25. PubMed ID: 30977158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis of treatment with rabbit and horse antithymocyte globulin for aplastic anemia.
    Hayakawa J; Kanda J; Akahoshi Y; Harada N; Kameda K; Ugai T; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Ashizawa M; Sato M; Terasako-Saito K; Kimura SI; Kikuchi M; Yamazaki R; Kako S; Kanda Y
    Int J Hematol; 2017 May; 105(5):578-586. PubMed ID: 28078653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of adults with severe aplastic anemia: primary therapy with antithymocyte globulin (ATG) and rescue of ATG failures with bone marrow transplantation.
    Crump M; Larratt LM; Maki E; Curtis JE; Minden MD; Meharchand JM; Lipton JH; Messner HA
    Am J Med; 1992 Jun; 92(6):596-602. PubMed ID: 1605140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.